APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hyperimmune Globulin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hyperimmune Globulin Injection Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchHyperimmune Globulin Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hyperimmune Globulin Injection Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Hyperimmune Globulin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hyperimmune Globulin Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hyperimmune Globulin Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Hyperimmune Globulin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hyperimmune Globulin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hyperimmune Globulin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hyperimmune Globulin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hyperimmune Globulin Injection include CNBG, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, CBPO, Kedrion, Kamada, Grifols and Emergent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hyperimmune Globulin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hyperimmune Globulin Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hyperimmune Globulin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hyperimmune Globulin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hyperimmune Globulin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hyperimmune Globulin Injection Market by Company

CNBG

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

CBPO

Kedrion

Kamada

Grifols

Emergent

CSL Behring

Biotest

ADMA Biologics

Hyperimmune Globulin Injection Segment by Type

Hepatitis B Immuneglobulins

Tetanus Toxin Immuneglobulins

Rabies Immuneglobulins

Rho(D) Immune Globulin

Cytomegalovirus Immune Globulin

Varicella-Zoster Immune Globulin

Others

Hyperimmune Globulin Injection Segment by Application

Government Institution

Private Sector

Others

Hyperimmune Globulin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hyperimmune Globulin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hyperimmune Globulin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hyperimmune Globulin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hyperimmune Globulin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hyperimmune Globulin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hepatitis B Immuneglobulins Table 2. Major Company of Tetanus Toxin Immuneglobulins Table 3. Major Company of Rabies Immuneglobulins Table 4. Major Company of Rho(D) Immune Globulin Table 5. Major Company of Cytomegalovirus Immune Globulin Table 6. Major Company of Varicella-Zoster Immune Globulin Table 7. Major Company of Others Table 8. Global Hyperimmune Globulin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 10. Global Hyperimmune Globulin Injection Sales Market Share in Volume by Type (2021-2026) Table 11. Global Hyperimmune Globulin Injection Sales by Type (2021-2026) & (US$ Million) Table 12. Global Hyperimmune Globulin Injection Sales Market Share in Value by Type (2021-2026) Table 13. Global Hyperimmune Globulin Injection Price by Type (2021-2026) & (US$/unit) Table 14. Global Hyperimmune Globulin Injection Sales by Type (2027-2032) & (k units) Table 15. Global Hyperimmune Globulin Injection Sales Market Share in Volume by Type (2027-2032) Table 16. Global Hyperimmune Globulin Injection Sales by Type (2027-2032) & (US$ Million) Table 17. Global Hyperimmune Globulin Injection Sales Market Share in Value by Type (2027-2032) Table 18. Global Hyperimmune Globulin Injection Price by Type (2027-2032) & (US$/unit) Table 19. North America Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 20. North America Hyperimmune Globulin Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 22. Europe Hyperimmune Globulin Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 24. Asia-Pacific Hyperimmune Globulin Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 26. Latin America Hyperimmune Globulin Injection Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Hyperimmune Globulin Injection Sales by Type (2021-2026) & (k units) Table 28. Middle East and Africa Hyperimmune Globulin Injection Sales by Type (2021-2026) & (US$ Million) Table 29. Hyperimmune Globulin Injection Industry Trends Table 30. Hyperimmune Globulin Injection Industry Drivers Table 31. Hyperimmune Globulin Injection Industry Opportunities and Challenges Table 32. Hyperimmune Globulin Injection Industry Restraints Table 33. Global Hyperimmune Globulin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Hyperimmune Globulin Injection Revenue Market Share by Company (2021-2026) Table 35. Global Hyperimmune Globulin Injection Sales by Company (2021-2026) & (k units) Table 36. Global Hyperimmune Globulin Injection Sales Share by Company (2021-2026) Table 37. Global Hyperimmune Globulin Injection Market Price by Company (2021-2026) & (US$/unit) Table 38. Global Hyperimmune Globulin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Hyperimmune Globulin Injection Major Company Production Sites and Headquarters Table 40. Global Hyperimmune Globulin Injection Company, Product Type & Application Table 41. Global Hyperimmune Globulin Injection Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Hyperimmune Globulin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Hyperimmune Globulin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Hyperimmune Globulin Injection Sales by Region (2021-2026) & (k units) Table 46. Global Hyperimmune Globulin Injection Sales Market Share in Volume by Region (2021-2026) Table 47. Global Hyperimmune Globulin Injection Sales by Region (2021-2026) & (US$ Million) Table 48. Global Hyperimmune Globulin Injection Sales Market Share in Value by Region (2021-2026) Table 49. Global Hyperimmune Globulin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 50. Global Hyperimmune Globulin Injection Sales by Region (2027-2032) & (k units) Table 51. Global Hyperimmune Globulin Injection Sales Market Share in Volume by Region (2027-2032) Table 52. Global Hyperimmune Globulin Injection Sales by Region (2027-2032) & (US$ Million) Table 53. Global Hyperimmune Globulin Injection Sales Market Share in Value by Region (2027-2032) Table 54. Global Hyperimmune Globulin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 55. Global Hyperimmune Globulin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 57. Global Hyperimmune Globulin Injection Sales Market Share in Volume by Application (2021-2026) Table 58. Global Hyperimmune Globulin Injection Sales by Application (2021-2026) & (US$ Million) Table 59. Global Hyperimmune Globulin Injection Sales Market Share in Value by Application (2021-2026) Table 60. Global Hyperimmune Globulin Injection Price by Application (2021-2026) & (US$/unit) Table 61. Global Hyperimmune Globulin Injection Sales by Application (2027-2032) & (k units) Table 62. Global Hyperimmune Globulin Injection Sales Market Share in Volume by Application (2027-2032) Table 63. Global Hyperimmune Globulin Injection Sales by Application (2027-2032) & (US$ Million) Table 64. Global Hyperimmune Globulin Injection Sales Market Share in Value by Application (2027-2032) Table 65. Global Hyperimmune Globulin Injection Price by Application (2027-2032) & (US$/unit) Table 66. North America Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 67. North America Hyperimmune Globulin Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 69. Europe Hyperimmune Globulin Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 71. Asia-Pacific Hyperimmune Globulin Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 73. Latin America Hyperimmune Globulin Injection Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Hyperimmune Globulin Injection Sales by Application (2021-2026) & (k units) Table 75. Middle East and Africa Hyperimmune Globulin Injection Sales by Application (2021-2026) & (US$ Million) Table 76. CNBG Company Information Table 77. CNBG Business Overview Table 78. CNBG Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. CNBG Hyperimmune Globulin Injection Product Portfolio Table 80. CNBG Recent Development Table 81. Sichuan Yuanda Shuyang Company Information Table 82. Sichuan Yuanda Shuyang Business Overview Table 83. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Portfolio Table 85. Sichuan Yuanda Shuyang Recent Development Table 86. Shanghai RAAS Company Information Table 87. Shanghai RAAS Business Overview Table 88. Shanghai RAAS Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Shanghai RAAS Hyperimmune Globulin Injection Product Portfolio Table 90. Shanghai RAAS Recent Development Table 91. Hualan Bio Company Information Table 92. Hualan Bio Business Overview Table 93. Hualan Bio Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Hualan Bio Hyperimmune Globulin Injection Product Portfolio Table 95. Hualan Bio Recent Development Table 96. CBPO Company Information Table 97. CBPO Business Overview Table 98. CBPO Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. CBPO Hyperimmune Globulin Injection Product Portfolio Table 100. CBPO Recent Development Table 101. Kedrion Company Information Table 102. Kedrion Business Overview Table 103. Kedrion Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Kedrion Hyperimmune Globulin Injection Product Portfolio Table 105. Kedrion Recent Development Table 106. Kamada Company Information Table 107. Kamada Business Overview Table 108. Kamada Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Kamada Hyperimmune Globulin Injection Product Portfolio Table 110. Kamada Recent Development Table 111. Grifols Company Information Table 112. Grifols Business Overview Table 113. Grifols Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Grifols Hyperimmune Globulin Injection Product Portfolio Table 115. Grifols Recent Development Table 116. Emergent Company Information Table 117. Emergent Business Overview Table 118. Emergent Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Emergent Hyperimmune Globulin Injection Product Portfolio Table 120. Emergent Recent Development Table 121. CSL Behring Company Information Table 122. CSL Behring Business Overview Table 123. CSL Behring Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. CSL Behring Hyperimmune Globulin Injection Product Portfolio Table 125. CSL Behring Recent Development Table 126. Biotest Company Information Table 127. Biotest Business Overview Table 128. Biotest Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Biotest Hyperimmune Globulin Injection Product Portfolio Table 130. Biotest Recent Development Table 131. ADMA Biologics Company Information Table 132. ADMA Biologics Business Overview Table 133. ADMA Biologics Hyperimmune Globulin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. ADMA Biologics Hyperimmune Globulin Injection Product Portfolio Table 135. ADMA Biologics Recent Development Table 136. North America Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. North America Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 138. North America Hyperimmune Globulin Injection Sales Market Share by Country (2021-2026) Table 139. North America Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 140. North America Hyperimmune Globulin Injection Sales Market Share Forecast by Country (2027-2032) Table 141. North America Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Hyperimmune Globulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Hyperimmune Globulin Injection Market Share by Country (2021-2026) Table 144. North America Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Hyperimmune Globulin Injection Market Share Forecast by Country (2027-2032) Table 146. Europe Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Europe Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 148. Europe Hyperimmune Globulin Injection Sales Market Share by Country (2021-2026) Table 149. Europe Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 150. Europe Hyperimmune Globulin Injection Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Hyperimmune Globulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Hyperimmune Globulin Injection Market Share by Country (2021-2026) Table 154. Europe Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Hyperimmune Globulin Injection Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 158. Asia-Pacific Hyperimmune Globulin Injection Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 160. Asia-Pacific Hyperimmune Globulin Injection Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Hyperimmune Globulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Hyperimmune Globulin Injection Market Share by Country (2021-2026) Table 164. Asia-Pacific Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Hyperimmune Globulin Injection Market Share Forecast by Country (2027-2032) Table 166. Latin America Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Latin America Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 168. Latin America Hyperimmune Globulin Injection Sales Market Share by Country (2021-2026) Table 169. Latin America Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 170. Latin America Hyperimmune Globulin Injection Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Hyperimmune Globulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Hyperimmune Globulin Injection Market Share by Country (2021-2026) Table 174. Latin America Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Hyperimmune Globulin Injection Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Hyperimmune Globulin Injection Sales by Country (2021-2026) & (k units) Table 178. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032) & (k units) Table 180. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Hyperimmune Globulin Injection Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Hyperimmune Globulin Injection Market Share by Country (2021-2026) Table 184. Middle East and Africa Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Hyperimmune Globulin Injection Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Hyperimmune Globulin Injection Distributors List Table 189. Hyperimmune Globulin Injection Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Hyperimmune Globulin Injection Image Figure 2. Global Hyperimmune Globulin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hyperimmune Globulin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Hyperimmune Globulin Injection Sales (2021-2032) & (k units) Figure 5. Hepatitis B Immuneglobulins Image Figure 6. Global Hepatitis B Immuneglobulins Sales YoY Growth (2021-2032) & (k units) Figure 7. Tetanus Toxin Immuneglobulins Image Figure 8. Global Tetanus Toxin Immuneglobulins Sales YoY Growth (2021-2032) & (k units) Figure 9. Rabies Immuneglobulins Image Figure 10. Global Rabies Immuneglobulins Sales YoY Growth (2021-2032) & (k units) Figure 11. Rho(D) Immune Globulin Image Figure 12. Global Rho(D) Immune Globulin Sales YoY Growth (2021-2032) & (k units) Figure 13. Cytomegalovirus Immune Globulin Image Figure 14. Global Cytomegalovirus Immune Globulin Sales YoY Growth (2021-2032) & (k units) Figure 15. Varicella-Zoster Immune Globulin Image Figure 16. Global Varicella-Zoster Immune Globulin Sales YoY Growth (2021-2032) & (k units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 19. Global Hyperimmune Globulin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Hyperimmune Globulin Injection Market Share by Type 2025 VS 2032 Figure 21. North America Hyperimmune Globulin Injection Sales Market Share in Volume by Type in 2025 Figure 22. North America Hyperimmune Globulin Injection Sales Market Share in Value by Type in 2025 Figure 23. Europe Hyperimmune Globulin Injection Sales Market Share in Volume by Type in 2025 Figure 24. Europe Hyperimmune Globulin Injection Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Hyperimmune Globulin Injection Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Hyperimmune Globulin Injection Sales Market Share in Value by Type in 2025 Figure 27. Latin America Hyperimmune Globulin Injection Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Hyperimmune Globulin Injection Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Hyperimmune Globulin Injection Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Government Institution Image Figure 34. Global Government Institution Sales YoY Growth (2021-2032) & (k units) Figure 35. Private Sector Image Figure 36. Global Private Sector Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Hyperimmune Globulin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Hyperimmune Globulin Injection Market Share by Application 2025 VS 2032 Figure 41. North America Hyperimmune Globulin Injection Sales Market Share in Volume by Application in 2025 Figure 42. North America Hyperimmune Globulin Injection Sales Market Share in Value by Application in 2025 Figure 43. Europe Hyperimmune Globulin Injection Sales Market Share in Volume by Application in 2025 Figure 44. Europe Hyperimmune Globulin Injection Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Hyperimmune Globulin Injection Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Hyperimmune Globulin Injection Sales Market Share in Value by Application in 2025 Figure 47. Latin America Hyperimmune Globulin Injection Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Hyperimmune Globulin Injection Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share in Value by Application in 2025 Figure 51. North America Hyperimmune Globulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Hyperimmune Globulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Hyperimmune Globulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Hyperimmune Globulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Hyperimmune Globulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Hyperimmune Globulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Hyperimmune Globulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Hyperimmune Globulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Hyperimmune Globulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Hyperimmune Globulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hyperimmune Globulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Hyperimmune Globulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Hyperimmune Globulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Hyperimmune Globulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Hyperimmune Globulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Hyperimmune Globulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Hyperimmune Globulin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Hyperimmune Globulin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Hyperimmune Globulin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Hyperimmune Globulin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Hyperimmune Globulin Injection Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Hyperimmune Globulin Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis B Immuneglobulins
  • Tetanus Toxin Immuneglobulins
  • Rabies Immuneglobulins
  • Rho(D) Immune Globulin
  • Cytomegalovirus Immune Globulin
  • Varicella-Zoster Immune Globulin
  • Others
Applications
  • Government Institution
  • Private Sector
  • Others
Companies covered
  • CNBG
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • CBPO
  • Kedrion
  • Kamada
  • Grifols
  • Emergent
  • CSL Behring
  • Biotest
  • ADMA Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hyperimmune Globulin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hyperimmune Globulin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hyperimmune Globulin Injection Market by Type
  6. 1.3.1 Hepatitis B Immuneglobulins
  7. 1.3.2 Tetanus Toxin Immuneglobulins
  8. 1.3.3 Rabies Immuneglobulins
  9. 1.3.4 Rho(D) Immune Globulin
  10. 1.3.5 Cytomegalovirus Immune Globulin
  11. 1.3.6 Varicella-Zoster Immune Globulin
  12. 1.3.7 Others
  13. 1.4 Global Hyperimmune Globulin Injection Market Size by Type
  14. 1.4.1 Global Hyperimmune Globulin Injection Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Hyperimmune Globulin Injection Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Hyperimmune Globulin Injection Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Hyperimmune Globulin Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Hyperimmune Globulin Injection Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Hyperimmune Globulin Injection Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Hyperimmune Globulin Injection Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Hyperimmune Globulin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hyperimmune Globulin Injection Industry Trends
  2. 2.2 Hyperimmune Globulin Injection Industry Drivers
  3. 2.3 Hyperimmune Globulin Injection Industry Opportunities and Challenges
  4. 2.4 Hyperimmune Globulin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hyperimmune Globulin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Hyperimmune Globulin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Hyperimmune Globulin Injection Price (2021-2026)
  4. 3.4 Global Hyperimmune Globulin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hyperimmune Globulin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Hyperimmune Globulin Injection Company, Product Type & Application
  7. 3.7 Global Hyperimmune Globulin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hyperimmune Globulin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hyperimmune Globulin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hyperimmune Globulin Injection Tier 1, Tier 2, and Tier 3
4 Hyperimmune Globulin Injection Regional Status and Outlook
  1. 4.1 Global Hyperimmune Globulin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hyperimmune Globulin Injection Historic Market Size by Region
  3. 4.2.1 Global Hyperimmune Globulin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hyperimmune Globulin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hyperimmune Globulin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hyperimmune Globulin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Hyperimmune Globulin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hyperimmune Globulin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hyperimmune Globulin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hyperimmune Globulin Injection by Application
  1. 5.1 Hyperimmune Globulin Injection Market by Application
  2. 5.1.1 Government Institution
  3. 5.1.2 Private Sector
  4. 5.1.3 Others
  5. 5.2 Global Hyperimmune Globulin Injection Market Size by Application
  6. 5.2.1 Global Hyperimmune Globulin Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hyperimmune Globulin Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hyperimmune Globulin Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hyperimmune Globulin Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hyperimmune Globulin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hyperimmune Globulin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hyperimmune Globulin Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hyperimmune Globulin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CNBG
  2. 6.1.1 CNBG Company Information
  3. 6.1.2 CNBG Business Overview
  4. 6.1.3 CNBG Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CNBG Hyperimmune Globulin Injection Product Portfolio
  6. 6.1.5 CNBG Recent Developments
  7. 6.2 Sichuan Yuanda Shuyang
  8. 6.2.1 Sichuan Yuanda Shuyang Company Information
  9. 6.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 6.2.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Portfolio
  12. 6.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 6.3 Shanghai RAAS
  14. 6.3.1 Shanghai RAAS Company Information
  15. 6.3.2 Shanghai RAAS Business Overview
  16. 6.3.3 Shanghai RAAS Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai RAAS Hyperimmune Globulin Injection Product Portfolio
  18. 6.3.5 Shanghai RAAS Recent Developments
  19. 6.4 Hualan Bio
  20. 6.4.1 Hualan Bio Company Information
  21. 6.4.2 Hualan Bio Business Overview
  22. 6.4.3 Hualan Bio Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Bio Hyperimmune Globulin Injection Product Portfolio
  24. 6.4.5 Hualan Bio Recent Developments
  25. 6.5 CBPO
  26. 6.5.1 CBPO Company Information
  27. 6.5.2 CBPO Business Overview
  28. 6.5.3 CBPO Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CBPO Hyperimmune Globulin Injection Product Portfolio
  30. 6.5.5 CBPO Recent Developments
  31. 6.6 Kedrion
  32. 6.6.1 Kedrion Company Information
  33. 6.6.2 Kedrion Business Overview
  34. 6.6.3 Kedrion Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kedrion Hyperimmune Globulin Injection Product Portfolio
  36. 6.6.5 Kedrion Recent Developments
  37. 6.7 Kamada
  38. 6.7.1 Kamada Company Information
  39. 6.7.2 Kamada Business Overview
  40. 6.7.3 Kamada Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kamada Hyperimmune Globulin Injection Product Portfolio
  42. 6.7.5 Kamada Recent Developments
  43. 6.8 Grifols
  44. 6.8.1 Grifols Company Information
  45. 6.8.2 Grifols Business Overview
  46. 6.8.3 Grifols Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Grifols Hyperimmune Globulin Injection Product Portfolio
  48. 6.8.5 Grifols Recent Developments
  49. 6.9 Emergent
  50. 6.9.1 Emergent Company Information
  51. 6.9.2 Emergent Business Overview
  52. 6.9.3 Emergent Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Emergent Hyperimmune Globulin Injection Product Portfolio
  54. 6.9.5 Emergent Recent Developments
  55. 6.10 CSL Behring
  56. 6.10.1 CSL Behring Company Information
  57. 6.10.2 CSL Behring Business Overview
  58. 6.10.3 CSL Behring Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CSL Behring Hyperimmune Globulin Injection Product Portfolio
  60. 6.10.5 CSL Behring Recent Developments
  61. 6.11 Biotest
  62. 6.11.1 Biotest Company Information
  63. 6.11.2 Biotest Business Overview
  64. 6.11.3 Biotest Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Biotest Hyperimmune Globulin Injection Product Portfolio
  66. 6.11.5 Biotest Recent Developments
  67. 6.12 ADMA Biologics
  68. 6.12.1 ADMA Biologics Company Information
  69. 6.12.2 ADMA Biologics Business Overview
  70. 6.12.3 ADMA Biologics Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ADMA Biologics Hyperimmune Globulin Injection Product Portfolio
  72. 6.12.5 ADMA Biologics Recent Developments
7 North America by Country
  1. 7.1 North America Hyperimmune Globulin Injection Sales by Country
  2. 7.1.1 North America Hyperimmune Globulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hyperimmune Globulin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hyperimmune Globulin Injection Market Size by Country
  6. 7.2.1 North America Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hyperimmune Globulin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hyperimmune Globulin Injection Sales by Country
  2. 8.1.1 Europe Hyperimmune Globulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hyperimmune Globulin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hyperimmune Globulin Injection Market Size by Country
  6. 8.2.1 Europe Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hyperimmune Globulin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hyperimmune Globulin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Hyperimmune Globulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hyperimmune Globulin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hyperimmune Globulin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hyperimmune Globulin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hyperimmune Globulin Injection Sales by Country
  2. 10.1.1 South America Hyperimmune Globulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hyperimmune Globulin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hyperimmune Globulin Injection Market Size by Country
  6. 10.2.1 South America Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hyperimmune Globulin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hyperimmune Globulin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Hyperimmune Globulin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hyperimmune Globulin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hyperimmune Globulin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hyperimmune Globulin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Hyperimmune Globulin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hyperimmune Globulin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hyperimmune Globulin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hyperimmune Globulin Injection Value Chain Analysis
  2. 12.1.1 Hyperimmune Globulin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hyperimmune Globulin Injection Production Mode & Process
  7. 12.2 Hyperimmune Globulin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hyperimmune Globulin Injection Distributors
  10. 12.2.3 Hyperimmune Globulin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst